Why the study?
Pericardial malignant mesothelioma is a rare tumour carrying an extremely poor prognosis, with frequently nonspecific symptoms and diagnosis typically made after surgery or at autopsy.
Surgical treatment of primary pericardial malignant mesothelioma can result in survival with good performance status at 9 months, despite the generally poor prognosis of the disease.
Pericardial malignant mesothelioma (MM) is a rare tumour which accounts for about 1% of all mesotheliomas, 4% of the primary heart and pericardial tumours. It carries an extremely poor prognosis, with a reported overall survival of less than 6 months. Clinical symptoms and signs are frequently nonspecific, and the diagnosis is usually made after surgery or at autopsy. We report a case of a 72 years old woman with primary pericardial malignant mesothelioma involving the right atrium. Nine months following surgery, the patient is alive with good performance status.
No takes yet. Share an insight, caveat, or question.
Apicella et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: